ZEISS MEL 90 excimer laser receives U.S. FDA approval; completes Corneal Refractive Workflow
CARL ZEISS MEDI UNSP/ADR (CZMWY)
NASDAQ:AMEX Investor Relations:
zeiss.com/meditec-ag/investor-relations.html
Company Research
Source: PR Newswire
The excimer laser complements the ZEISS VISUMAX 800 with ZEISS SMILE pro, extending ZEISS' LVC market leadership with treatment for myopia, hyperopia, and mixed astigmatism.DUBLIN, Calif. and JENA, Germany, Jan. 13, 2025 /PRNewswire/ -- ZEISS Medical Technology announced today that the MEL® 90 received approval from the U.S. Food and Drug Administration (FDA), giving the excimer laser technology simultaneous approval for all three major indications, including myopia, hyperopia and mixed astigmatism (a condition where both hyperopic and myopic correction is required). The ZEISS MEL 90 fully integrates into the Corneal Refractive Workflow to offer U.S. surgeons a fast, reliable, and streamlined surgery experience, complementi
Read more
Impact Snapshot
Event Time:
CZMWY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CZMWY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CZMWY alerts
High impacting CARL ZEISS MEDI UNSP/ADR news events
Weekly update
A roundup of the hottest topics
CZMWY
News
- Carl Zeiss Meditec AG (OTCMKTS: CZMWY) was downgraded by analysts at HSBC Holdings plc to a "reduce" rating.MarketBeat
- ILM-Blue from DORC Receives NMPA Approval in China; Expanding Global Reach [Yahoo! Finance]Yahoo! Finance
- ILM-Blue from DORC Receives NMPA Approval in China; Expanding Global ReachPR Newswire
- ILM-Blue from DORC Receives NMPA Approval in China; Expanding Global ReachPR Newswire
- ILM-Blue from DORC Receives NMPA Approval in China; Expanding Global ReachPR Newswire